Advertisement · 728 × 90

Posts by

Infectious Disease 2025 - Current Topics Virtual Conference, 7.50 ACCME Credits

Join us for our virtual ‘Current Topics in #InfectiousDisease Symposium’ on 11/7/25. A must for #Hospitalists and other practitioners. We will cover the latest in MDR infections and best practices for prevention and treatment! Check it out: www.eventleaf.com/e/ID2025 @cuimcmedicinedept.bsky.social

5 months ago 1 1 0 0
Current Topics in Infectious Disease 2025 Virtual Conference, 7.50 ACCME Credits

Join us for our virtual ‘Current Topics in #InfectiousDisease Symposium’ on 11/7, 2025. A must for #Hospitalists and other practitioners. We will cover the latest in antibiotics, infections, prevention and vaccines! Click for info and registration: www.eventleaf.com/e/ID2025

6 months ago 0 0 0 0
Post image

Our members are the best! (Completely biased opinion) #WTC2025 #TxID

8 months ago 17 6 1 0

So well deserved!

8 months ago 2 0 0 0

Good times!

8 months ago 1 0 0 0

Great AST ID COP MDRO workgroup meeting today! Excited that @amishkin.bsky.social is now the chair and I can’t wait to see what the group does next! @astinfo.bsky.social @txidfellows.bsky.social @ast-idcop.bsky.social

8 months ago 1 0 0 1
Post image

AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate.

ajt-transplant-id-exchange.squarespace.com

9 months ago 9 8 0 1
Post image Post image

Joint #TxID happy hour🍹with Weill Cornell and Columbia #TxID faculty to welcome our newest NYP TxID fellow, Gabe! #IDsky

9 months ago 2 1 1 0

Great time last evening to hang out with our new TxID fellow Gabriel. Welcome Gabriel! It'll be a great year!

9 months ago 0 0 0 0
Advertisement
Preview
Advanced Fellowship in Transplant Infectious Diseases (TID) Explore our one-year Advanced Fellowship in Transplant Infectious Diseases, offering expert training across Columbia, Weill Cornell, and NewYork-Presbyterian.

Excited to announce a new opportunity for those interested in advancing their careers in TID! Columbia and Cornell now offer a combined advanced TID fellowship! Check us out and apply! @rosypriya.bsky.social @txidfellows.bsky.social
www.infectiousdiseases.cuimc.columbia.edu/education/ad...

9 months ago 4 3 0 0

Fantastic podcast from @alemendoza.bsky.social and @aussiedocwolfe.bsky.social. Very well done. Not sure about others, but I’m suddenly much more concerned about our ability to respond to an outbreak of human to human transmission after today’s news.

10 months ago 1 0 1 0
Preview
CMV Stream 2025 - CMV STREAM CMV Management in Solid Organ Transplantation Insights and Challenges from the New 4th Consensus Guidelines Watch the recording Watch CMV Stream 2025 for an in-depth discussion on challenging issues a...

Excited to share our updated CMVStream, discussing the updated international CMV guidelines and challenging aspects of management after organ transplant cmvstream.com @mpereiramd.bsky.social

10 months ago 6 2 0 0
Post image

Looking forward to CMV Stream 2025 later today! Join me and the rest of the panel members for a lively discussion on the recently published 4th International Consensus Guidelines on the management of CMV in SOT today at 3 PM EST. See you there!

11 months ago 0 0 0 0
Post image

Please join us this Friday at 3 PM EST for an update on the updated CMV in solid organ transplant guidelines and great discussion on the nuances. Submit questions to us during the live stream.

1 year ago 7 6 3 1

AST ID COP Townhall happening now! Join us to hear some exciting developments and to have your voice heard! @astinfo.bsky.social

1 year ago 1 0 0 0

@jason10033.bsky.social is one of the most amazing and dedicated doctors that I know. Congratulations Jason!

1 year ago 3 0 0 0
Advertisement
Preview
Maribavir for refractory cytomegalovirus infection (with or without resistance) in solid organ transplant recipients: subgroup analysis of the phase 3 randomized SOLSTICE study - PubMed ClinicalTrials.gov; NCT02931539 DATA AVAILABILITY STATEMENT: The datasets, including the redacted study protocol, redacted statistical analysis plan, and individual participants data supporting the re...

The results of the SOT subgroup analysis of the SOLTICE Phase III RCT (Maribavir vs. IAT) are consistent with those of the overall population. > Effectiveness < Discontinuations. #TxID #IDSky #ViroSky #MedSky pubmed.ncbi.nlm.nih.gov/39613120/

1 year ago 18 6 2 0

This is a great opportunity for new faculty, including in Transplant ID!

1 year ago 1 0 0 0

100% agree!

1 year ago 0 0 0 0

I am so excited to work with our future Columbia ID fellows Melissa, Ann and Jeff! Congratulations!!!

1 year ago 1 0 0 0
Post image

Greetings #IDSky! Thrilled to welcome Melissa, Jeff, and Ann to our ID fellowship program!!!! ❤️‍🌟

1 year ago 29 4 0 1

this looks great!

1 year ago 0 0 0 0

Hey everyone! Excited to be joining this platform and interacting with my amazing colleagues and friends once more! This looks great!

1 year ago 11 0 1 0